Over‐expression of fibroblast growth factor‐2 causes defective bone mineralization and osteopenia in transgenic mice
- 18 February 2005
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 95 (1) , 83-94
- https://doi.org/10.1002/jcb.20389
Abstract
Over‐expression of human FGF‐2 cDNA linked to the phosphoglycerate kinase promoter in transgenic (TgFGF2) mice resulted in a dwarf mouse with premature closure of the growth plate and shortening of bone length. This study was designed to further characterize bone structure and remodeling in these mice. Bones of 1–6 month‐old wild (NTg) and TgFGF2 mice were studied. FGF‐2 protein levels were higher in bones of TgFGF2 mice. Bone mineral density was significantly decreased as early as 1 month in femurs from TgFGF2 mice compared with NTg mice. Micro‐CT of trabecular bone of the distal femurs from 6‐month‐old TgFGF2 mice revealed significant reduction in trabecular bone volume, trabecular number (Tb.N), and increased trabecular separation (Tb.Sp). Osteoblast surface/bone surface, double‐labeled surface, mineral apposition rate, and bone formation rates were all significantly reduced in TgFGF2 mice. There were fewer TRAP positive osteoclasts in calvaria from TgFGF2 mice. Quantitative histomorphometry showed that total bone area was similar in both genotypes, however percent osteoclast surface, and osteoclast number/bone surface were significantly reduced in TgFGF2 mice. Increased replication of TgFGF2 calvarial osteoblasts was observed and primary cultures of bone marrow stromal cells from TgFGF2 expressed markers of mature osteoblasts but formed fewer mineralized nodules. The data presented indicate that non‐targeted over‐expression of FGF‐2 protein resulted in decreased endochondral and intramembranous bone formation. These results are consistent with FGF‐2 functioning as a negative regulator of postnatal bone growth and remodeling in this animal model.Keywords
This publication has 59 references indexed in Scilit:
- Basic Fibroblast Growth Factor Induces Osteoclast Formation by Reciprocally Regulating the Production of Osteoclast Differentiation Factor and Osteoclastogenesis Inhibitory Factor in Mouse Osteoblastic CellsBiochemical and Biophysical Research Communications, 1999
- Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In VitroJournal of Bone and Mineral Research, 1998
- Skeletal disorders associated with fibroblast growth factor receptor mutatiosCurrent Opinion in Genetics & Development, 1997
- Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3Nature Genetics, 1996
- Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3Nature Genetics, 1995
- Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells.The Journal of cell biology, 1994
- Cell Cycle-Dependent Localization of Irnmunoreactive Basic Fibroblast Growth Factor to Cytoplasm and Nucleus of Isolated Ovine Fetal Growth Plate ChondrocytesGrowth Factors, 1992
- Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.The Journal of cell biology, 1990
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979